Furthermore, LPL is a rate-restricting enzyme for the hydrolysis of TG in chylomicrons and VLDL [11], and it has been suggested that the level of LPL activity in muscle relative to that in adipose tissue determines body mass composition and contributes to obesity by influencing the rate at which fatty acids derived from TG are used or stored [10]. The gene discussed is LPL; the disease is Obesity.